Related Experiment Video
Updated: Jan 16, 2026

09:29
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.6K
Multi-Locus Pro-Dopaminergic Restoration of Reward Brain Circuitry in Reward Deficiency Rescinds Mono-Pharmaceutical
Kenneth Blum1,2,3,4, Kavya Mohankumar3, Debasis Bagchi5
1Center for Exercise and Sport Mental Health, Western University Health Sciences, Pomona, USA.
Summary
The pro-dopaminergic nutraceutical KB220 enhances brain connectivity in reward circuitry, potentially aiding in addiction treatment by supporting dopamine homeostasis and reducing cravings.
Area of Science:
- Neuroscience
- Psychiatry
- Nutraceutical Science
Background:
- Dopaminergic dysfunction in reward circuitry is linked to addictive behaviors.
- Altered neural synchrony between reward and cognitive brain regions contributes to substance use disorders.
Purpose of the Study:
- To highlight findings on the pro-dopaminergic nutraceutical KB220's effects on brain reward circuitry.
- To propose multi-loci dopaminergic restoration as a paradigm for mental illness.
Main Methods:
- Review of animal studies demonstrating KB220's activation of reward regions and enhancement of functional connectivity.
- Human studies showing KB220's effect on BOLD activation in dopaminergic pathways in abstinent individuals.
- Analysis of data from 36 clinical trials and preclinical studies.
Main Results:
- KB220 enhances functional connectivity, neuroplasticity, and dopaminergic functionality in specific brain reward regions.
- KB220 supports "dopamine homeostasis" across reward deficiency behaviors.
- KB220 shows potential anti-craving and anti-relapse effects, supported by clinical and qEEG data.
Conclusions:
- KB220 demonstrates potential for addiction and psychiatric disorder treatment through dopaminergic modulation.
- Multi-loci dopaminergic restoration is proposed as a fundamental paradigm for mental illness treatment.
- KB220's localized effects on reward circuitry offer a targeted therapeutic approach.
Keywords:
Alcohol Use Disorder (AUD)Genome-Wide Association Studies (GWAS)KB220Quantitative Electroencephalogy (qEEG)Reward Deficiency (RD)More Related Videos
Related Concept Videos
Neurochemical Transmission: Sites of Drug Action
3.4K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.4K
Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K

